Island Pharmaceuticals Ltd (ILA) — Financial Flexibility Index
Island Pharmaceuticals Ltd (ILA) has a Financial Flexibility Index of -5.03x as of June 2025. Free cash flow of AU$-1.69 Million (operating CF AU$-1.69 Million minus capex AU$5.00) represents -5% of total liabilities (AU$336.43K). Also explore net asset growth rate of Island Pharmaceuticals Ltd to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Island Pharmaceuticals Ltd Financial Flexibility Index (2019–2024)
Historical Financial Flexibility Index trend for Island Pharmaceuticals Ltd across 6 annual periods. See how leveraged is Island Pharmaceuticals Ltd's balance sheet to measure how much of total assets are equity-financed.
Annual Financial Flexibility Index for Island Pharmaceuticals Ltd (2019–2024)
Year-by-year free cash flow to debt coverage for Island Pharmaceuticals Ltd. For the full company profile including market capitalisation, see ILA company net worth.
| Year | Flexibility Index | Free Cash Flow (AUD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -8.23x | AU$-2.77 Million | AU$-2.77 Million | AU$336.43K | ▼ -171.9% |
| 2023 | -3.03x | AU$-3.16 Million | AU$-3.16 Million | AU$1.05 Million | ▲ +70.5% |
| 2022 | -10.27x | AU$-2.71 Million | AU$-2.71 Million | AU$263.85K | ▼ -217.5% |
| 2021 | -3.23x | AU$-1.88 Million | AU$-1.88 Million | AU$580.73K | ▲ +18.4% |
| 2020 | -3.96x | AU$-938.23K | AU$-938.24K | AU$236.83K | ▼ -16588.4% |
| 2019 | -0.02x | AU$-16.00 | AU$-16.00 | AU$674.00 | — |